Diasorin Molecular -Molecular Rapid Qualitative Screening

SUNY Upstate Medical University seeks to purchase Diasorin Molecular Reagents and Related Products from a contract awarded by Premier pursuant to its authority under section 163 (3) (vi), which authorizes the purchases of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell equivalent Molecular Rapid Qualitative Screening reagents and Related Products may, if interested, contact Sheree Banks by email to discuss this procurement.

Equivalency must be demonstrated by meeting the clinical performance of the Diasorin Molecular reagents and Related Products. If offering a clinical equivalent, the vendor must provide free supporting clinical documentation, and equipment for examination, demonstration, and trial. Vendor must be authorized to see Diasorin Molecular Reagents/Products as listed on the Premier contract or approved equivalent.

This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Contacting any other individuals at Upstate in connection with this advertisement may constitute a violation of New York State Finance Law. Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency.

Successful vendor will be required to complete and submit applicable documents related to Vendor Responsibility, NYS Finance Law §139 j&k, and New York State’s Tax Law Section 5-a.

Successful vendor shall be required to submit valid and current NYS “Workman’s Compensation and Disability Forms.

Anyone who can provide the above described product is invited to contact SUNY Upstate Medical University’s Hospital Purchasing Department as shown below.